Fri, Dec 10, 2021
Homegrown pharma major Lupin Ltd on Friday announced the launch of its diagnostics arm as part of its strategy to provide integrated healthcare in India.
More >
Tue, Aug 02, 2016
Pharma company Lupin's Japanese subsidiary Kyowa Pharmaceutical Industry has entered into a strategic asset purchase agreement with Shionogi & Co., on August 1.
Thu, May 19, 2016
The company's net profit during the quarter was up by 47.55% to Rs 8,071 million as against Rs 5,470 million in the same period of the previous fiscal, Lupin said in a filing to the Bombay Stock Exchange (BSE) on Thursday.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
